Fig. 3From: Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosisDrug and nanoparticle targeting strategies. Small molecule drugs, scFv, IgG and recombinant antibody–drug fusion complexes; liposomes conjugated with binding molecules; polymeric nanoparticles conjugated with binding molecules; and membrane-coated nanoparticlesBack to article page